These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24089567)

  • 1. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells.
    Saghafian-Hedengren S; Sohlberg E; Theorell J; Carvalho-Queiroz C; Nagy N; Persson JO; Nilsson C; Bryceson YT; Sverremark-Ekström E
    J Virol; 2013 Dec; 87(24):13446-55. PubMed ID: 24089567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.
    Sohlberg E; Saghafian-Hedengren S; Rasul E; Marchini G; Nilsson C; Klein E; Nagy N; Sverremark-Ekström E
    J Immunol; 2013 Dec; 191(11):5669-76. PubMed ID: 24140645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and cytomegalovirus are differentially associated with numbers of cytokine-producing cells and early atopy.
    Nilsson C; Larsson Sigfrinius AK; Montgomery SM; Sverremark-Ekström E; Linde A; Lilja G; Blomberg MT
    Clin Exp Allergy; 2009 Apr; 39(4):509-17. PubMed ID: 19055650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation.
    Zhou JR; Shi DY; Wei R; Wang Y; Yan CH; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
    Front Immunol; 2020; 11():620891. PubMed ID: 33664733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.
    Hendricks DW; Balfour HH; Dunmire SK; Schmeling DO; Hogquist KA; Lanier LL
    J Immunol; 2014 May; 192(10):4492-6. PubMed ID: 24740502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age.
    Müller-Durovic B; Grählert J; Devine OP; Akbar AN; Hess C
    Aging (Albany NY); 2019 Jan; 11(2):724-740. PubMed ID: 30686790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus- and Epstein-Barr Virus-Induced T-Cell Expansions in Young Children Do Not Impair Naive T-cell Populations or Vaccination Responses: The Generation R Study.
    van den Heuvel D; Jansen MA; Dik WA; Bouallouch-Charif H; Zhao D; van Kester KA; Smits-te Nijenhuis MA; Kolijn-Couwenberg MJ; Jaddoe VW; Arens R; van Dongen JJ; Moll HA; van Zelm MC
    J Infect Dis; 2016 Jan; 213(2):233-42. PubMed ID: 26142434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-Parameter FluoroSpot Assay Reveals That the Varicella Zoster Virus Elicits a Robust Memory T Cell IL-10 Response throughout Childhood.
    Nilsson A; Höbinger A; Jahnmatz P; Tiselius E; Laestadius Å; Melén E; Björkander S; Saghafian-Hedengren S
    J Virol; 2022 Nov; 96(22):e0131022. PubMed ID: 36314824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children.
    Sohn MJ; Cho JM; Moon JS; Ko JS; Yang HR
    Medicine (Baltimore); 2018 Sep; 97(38):e12380. PubMed ID: 30235701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and Liver Biomarkers Profile of Epstein-Barr Virus Infection and Its Coinfection with Cytomegalovirus in Patients with Hematological Diseases.
    Ferrari de Freitas L; de Melo Silva J; Nogueira Barbosa A; Miranda Santos E; Pinheiro-Silva R; Soares Pontes G
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical Cytomegalovirus and Epstein-Barr Virus Shedding Is Associated with Increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
    Chaillon A; Nakazawa M; Rawlings SA; Curtin G; Caballero G; Scott B; Anderson C; Gianella S
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32641485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and reactivation of latent herpesviruses in older adults.
    Bennett JM; Glaser R; Malarkey WB; Beversdorf DQ; Peng J; Kiecolt-Glaser JK
    Brain Behav Immun; 2012 Jul; 26(5):739-46. PubMed ID: 22155500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection.
    Caduff N; McHugh D; Rieble L; Forconi CS; Ong'echa JM; Oluoch PO; Raykova A; Murer A; Böni M; Zuppiger L; Schulz TF; Blackbourn DJ; Chijioke O; Moormann AM; Münz C
    Cell Rep; 2021 May; 35(5):109056. PubMed ID: 33951431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of Epstein-Barr virus and cytomegalovirus on childhood respiratory health: A population-based prospective cohort study.
    van Meel ER; Jaddoe VWV; Reiss IKM; van Zelm MC; de Jongste JC; Moll HA; Duijts L
    Clin Exp Allergy; 2020 Apr; 50(4):499-507. PubMed ID: 32037652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
    Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
    Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
    Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
    Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application.
    Zuo W; Zhao X
    Clin Immunol; 2021 Jun; 227():108727. PubMed ID: 33887436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.